⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

July 1, 2024

Figure S1 from Genotoxicity Associated with Retroviral CAR Transduction of ATM-Deficient T Cells

Meir Rozenbaum Reut Fluss Victoria Marcu‐Malina Ifat Sarouk Amilia Meir Sarah Elitzur Tal Zinger Jasmine Jacob‐Hirsch Efrat G. Saar Gideon Rechavi Elad Jacoby

View at Publisher

Ask AI

Bookmark

Share

Abstract

This is the authors' abstract. We don't add key points for this paper.

Viability of CAR-T cells from ATM+/+, ATM+/- and ATM-/- donors at the end of production

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Rozenbaum et al. (2024) studied this question.

synapsesocial.com/papers/68e62195b6db6435875b36b6 https://doi.org/10.1158/2643-3230.26134513

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Figure S2 from Genotoxicity Associated with Retroviral CAR Transduction of <i>ATM</i>-Deficient T Cells2024
2Figure S3 from Genotoxicity Associated with Retroviral CAR Transduction of <i>ATM</i>-Deficient T Cells2024
3Table S2 from Genotoxicity Associated with Retroviral CAR Transduction of <i>ATM</i>-Deficient T Cells2024
4Table S2 from Genotoxicity Associated with Retroviral CAR Transduction of <i>ATM</i>-Deficient T Cells2024
5Table S3 from Genotoxicity Associated with Retroviral CAR Transduction of <i>ATM</i>-Deficient T Cells2024

Table S3 from Genotoxicity Associated with Retroviral CAR Transduction of <i>ATM</i>-Deficient T Cells2024
Figure S4 from Genotoxicity Associated with Retroviral CAR Transduction of <i>ATM</i>-Deficient T Cells2024
Table S4 from Genotoxicity Associated with Retroviral CAR Transduction of <i>ATM</i>-Deficient T Cells2024